Tag: GlobalData
CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion...
According to GlobalData’s Pharmaceutical Intelligence Center Deals Database, licensing agreements for innovator oligonucleotides targeting CNS indications secured a cumulative total deal value of $6.05 billion from 2021 to 2025 YTD
Cell and gene therapy market set to grow at 31.3% CAGR...
Significant advancements in treatments for dermatology disorders are anticipated, driven by innovations from both small to mid-size pharma and biotech companies
Biotech IPOs surge 68.4% YoY to $8.52 billion in 2024 amid...
According to GlobalData’s Pharmaceutical Intelligence Center Deals Database, completed IPOs that raised more than $100 million almost doubled, from $4.39 billion across 15 IPOs in 2023 to $7.88 billion across 24 IPOs in 2024
Coronary stents market in APAC to see sustained growth through 2034:...
The market is poised to grow at a compound annual growth rate (CAGR) of 3.2% in APAC between 2024 and 2034, outpacing the global CAGR of 1.2% over the same period
Pharma majors expand US manufacturing amid tariff pressures as BRICS boost...
GlobalData’s Emerging Market Outsourcing report reveals that this push for domestic production could lead to increased production costs and inflationary pressures on drug prices
FDA drug approvals drop 15.44% but smaller pharma leads innovation, reveals...
GlobalData’s Bio/Pharmaceutical Outsourcing report sheds light on the reliance of smaller pharma companies on contract development and manufacturing organizations (CDMOs) for production
Trump’s NIH funding cuts & freezes raise concerns over US biotech...
According to GlobalData’s Pharma Intelligence Center Grants Database, SBIR and STTR grants involving innovator drugs saw a 37% increase in total grant value from $237 million in 2020 to $326 million in 2024
Amgen strategic hiring push in India: GlobalData insights on R&D growth...
The company is focused on developing and implementing innovative strategies for indirect materials procurement, overseeing data analytics governance, and to improve procurement processes
Lilly’s GBP279 million investment set to boost UK life sciences sector
As per GlobalData, the initiative is set to accelerate early-stage ventures and spearhead advancements in obesity treatments, invigorating the UK life sciences sector
Biologic therapies mark progress in severe asthma treatment & remission potential:...
While biologics have shown great promise, barriers such as cost, access, and insurance coverage limit their availability, particularly in underserved communities